SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 19.00
-0.70 (-3.55%)
Mar 2, 2026, 5:24 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1.01 billion as of March 2, 2026. Its market cap has increased by 31.92% in one year.
Market Cap
1.01B
Enterprise Value
957.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
19.00
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.01B, an increase of 1,483.07%. That is a compound annual growth rate of 33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.01B | -16.26% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 2.57B |
| Diamyd Medical AB | 2.04B |
| Egetis Therapeutics AB | 1.81B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |
| Xspray Pharma AB | 1.09B |
| Medivir AB | 864.03M |